Regenerative medicine for oesophageal reconstruction after cancer treatment
Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-she...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/82779 http://hdl.handle.net/10220/25831 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-82779 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-827792023-03-04T17:14:06Z Regenerative medicine for oesophageal reconstruction after cancer treatment Chian, Kerm Sin Leong, Meng Fatt Kono, Koji School of Mechanical and Aerospace Engineering DRNTU::Science::Medicine::Tissue engineering Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-sheet technology have improved scaffold materials for oesophageal repair. Despite the many successful animal studies, few tissue-engineering approaches have progressed to clinical trials. In this Review, we discuss the status of oesophagus reconstruction after surgery. In particular, we highlight two clinical trials that used decellularised constructs and epithelial cell sheets to replace excised tissues after endoscopic submucosal dissection or mucosal resection procedures. Results from the trials showed that both decellularised grafts and epithelial-cell sheets prevented stenosis. By contrast, animal studies have shown that the use of tissue-engineered constructs after oesophagectomy remains a challenge. ASTAR (Agency for Sci., Tech. and Research, S’pore) Accepted Version 2015-06-08T06:36:33Z 2019-12-06T15:05:23Z 2015-06-08T06:36:33Z 2019-12-06T15:05:23Z 2015 2015 Journal Article Chian, K. S., Leong, M. F., & Kono, K. (2015). Regenerative medicine for oesophageal reconstruction after cancer treatment. The lancet oncology, 16(2), e84-e92. 1470-2045 https://hdl.handle.net/10356/82779 http://hdl.handle.net/10220/25831 10.1016/S1470-2045(14)70410-3 en The lancet oncology © 2015 Elsevier. This is the author created version of a work that has been peer reviewed and accepted for publication by The Lancet Oncology, Elsevier. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1016/S1470-2045(14)70410-3]. 9 p. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
DRNTU::Science::Medicine::Tissue engineering |
spellingShingle |
DRNTU::Science::Medicine::Tissue engineering Chian, Kerm Sin Leong, Meng Fatt Kono, Koji Regenerative medicine for oesophageal reconstruction after cancer treatment |
description |
Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-sheet technology have improved scaffold materials for oesophageal repair. Despite the many successful animal studies, few tissue-engineering approaches have progressed to clinical trials. In this Review, we discuss the status of oesophagus reconstruction after surgery. In particular, we highlight two clinical trials that used decellularised constructs and epithelial cell sheets to replace excised tissues after endoscopic submucosal dissection or mucosal resection procedures. Results from the trials showed that both decellularised grafts and epithelial-cell sheets prevented stenosis. By contrast, animal studies have shown that the use of tissue-engineered constructs after oesophagectomy remains a challenge. |
author2 |
School of Mechanical and Aerospace Engineering |
author_facet |
School of Mechanical and Aerospace Engineering Chian, Kerm Sin Leong, Meng Fatt Kono, Koji |
format |
Article |
author |
Chian, Kerm Sin Leong, Meng Fatt Kono, Koji |
author_sort |
Chian, Kerm Sin |
title |
Regenerative medicine for oesophageal reconstruction after cancer treatment |
title_short |
Regenerative medicine for oesophageal reconstruction after cancer treatment |
title_full |
Regenerative medicine for oesophageal reconstruction after cancer treatment |
title_fullStr |
Regenerative medicine for oesophageal reconstruction after cancer treatment |
title_full_unstemmed |
Regenerative medicine for oesophageal reconstruction after cancer treatment |
title_sort |
regenerative medicine for oesophageal reconstruction after cancer treatment |
publishDate |
2015 |
url |
https://hdl.handle.net/10356/82779 http://hdl.handle.net/10220/25831 |
_version_ |
1759854970022133760 |